Table 4.
Outcome | ASAQ1 (N = 310) |
ASAQ2 (N = 315) |
AL (N = 311) |
Total 5 |
Possible failure (information unavailable) | 12 (3.9%) |
16 (5.1%) |
9 (2.9%) |
37 (4.0%) |
Late clinical failure | None | None | 2 (0.6%) |
2 (0.2%) |
Late parasitological failure | 3 (1.0%) |
None | 3 (1.0%) |
6 (0.6%) |
Adequate clinical and parasitological response | 295 (95.2%) |
299 (94.9%) |
297 (95.5%) |
891 (95.2%) |